QURE
uniQure NV
NASDAQ · Healthcare · Biotechnology · NL
$23.03
−3.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 28.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.93x
- Price / sales
- 85.56x
- Price / cash flow
- -9.94x
Enterprise value
- Enterprise value
- $850.0M
- EV / sales
- 45.52x
- EV / EBITDA
- -4.69x
- EV / EBIT
- -4.18x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026